• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性高血压对良性前列腺增生患者前列腺动脉阻力指数的影响。

The effect of systemic hypertension on prostatic artery resistive indices in patients with benign prostate enlargement.

作者信息

Onigbinde Stephen O, Asaleye Christianah M, Salako Abdulkadir A, Idowu Bukunmi M, Onigbinde Abimbola O, Laoye Adeyinka

机构信息

Department of Anatomical Sciences, School of Medicine, St George's University, Grenada.

Department of Radiology, Obafemi Awolowo University and Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Osun State, Nigeria.

出版信息

Prostate Int. 2023 Mar;11(1):46-50. doi: 10.1016/j.prnil.2022.09.001. Epub 2022 Sep 27.

DOI:10.1016/j.prnil.2022.09.001
PMID:36910898
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9995693/
Abstract

BACKGROUND

To investigate the effect of systemic hypertension on the prostatic artery resistive indices by a comparative ultrasonographic evaluation of the prostate gland in normotensive and hypertensive patients with benign prostatic enlargement (BPE).

MATERIALS AND METHODS

The participants had BPE and presented at the outpatient urologic clinic of a tertiary hospital. They were divided into normotensive and hypertensive groups. Each group had fifty patients. Calculation of international prostate symptom score, measurement of blood pressure, and transrectal ultrasonographic evaluation were done.

RESULTS

The mean age for the normotensive and hypertensive groups were 66.9 ± 9.8 and 66.0 ± 10.7 years, respectively ( = 0.662). Patients with hypertensive BPE had a significantly higher mean transitional zone volume, transitional zone index, presumed circle area ratio, quality of life score, and prostatic arterial resistive indices than the age-matched normotensive BPE patients.

CONCLUSION

Patients with BPE and with hypertension had significantly higher prostate arteries resistive indices than normotensives with BPE. Even in patients with BPE and controlled hypertension, the prostatic artery resistance indices were still elevated than that of normotensive men with BPE.

摘要

背景

通过对患有良性前列腺增生(BPE)的血压正常和高血压患者的前列腺进行超声对比评估,研究系统性高血压对前列腺动脉阻力指数的影响。

材料与方法

参与者患有BPE,在一家三级医院的门诊泌尿外科就诊。他们被分为血压正常组和高血压组。每组有50名患者。进行国际前列腺症状评分计算、血压测量和经直肠超声评估。

结果

血压正常组和高血压组的平均年龄分别为66.9±9.8岁和66.0±10.7岁(P = 0.662)。与年龄匹配的血压正常的BPE患者相比,高血压BPE患者的平均移行区体积、移行区指数、假定圆面积比、生活质量评分和前列腺动脉阻力指数显著更高。

结论

患有BPE和高血压的患者的前列腺动脉阻力指数显著高于患有BPE的血压正常者。即使在患有BPE且高血压得到控制的患者中,前列腺动脉阻力指数仍高于患有BPE的血压正常男性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9ab/9995693/11a1dca31a9d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9ab/9995693/a3db87a580ce/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9ab/9995693/11a1dca31a9d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9ab/9995693/a3db87a580ce/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9ab/9995693/11a1dca31a9d/gr2.jpg

相似文献

1
The effect of systemic hypertension on prostatic artery resistive indices in patients with benign prostate enlargement.系统性高血压对良性前列腺增生患者前列腺动脉阻力指数的影响。
Prostate Int. 2023 Mar;11(1):46-50. doi: 10.1016/j.prnil.2022.09.001. Epub 2022 Sep 27.
2
Correlation of Doppler ultrasound resistive index in the prostatic gland with severity of male lower urinary tract symptoms, prostate volume, and concomitant diabetes mellitus.前列腺多普勒超声阻力指数与男性下尿路症状严重程度、前列腺体积及合并糖尿病的相关性。
Cent European J Urol. 2023;76(3):199-206. doi: 10.5173/ceju.2023.47. Epub 2023 Jul 13.
3
Transrectal Doppler Sonography of Benign Prostatic Enlargement in Nigerian Men.尼日利亚男性良性前列腺增生的经直肠多普勒超声检查
J Med Ultrasound. 2019 May 13;27(4):169-176. doi: 10.4103/JMU.JMU_102_18. eCollection 2019 Oct-Dec.
4
Obesity in benign prostatic enlargement: A cross-sectional study comparing sonographic and anthropometric indices of adiposity in a tertiary hospital in Southwestern Nigeria.良性前列腺增生中的肥胖:一项横断面研究,比较尼日利亚西南部一家三级医院中肥胖的超声和人体测量指标。
Niger J Clin Pract. 2019 Nov;22(11):1600-1605. doi: 10.4103/njcp.njcp_165_19.
5
Resistive index of prostate capsular arteries: a newly identified parameter to diagnose and assess bladder outlet obstruction in patients with benign prostatic hyperplasia.前列腺包膜动脉阻力指数:一种新的诊断和评估良性前列腺增生患者膀胱出口梗阻的参数。
J Urol. 2012 Sep;188(3):881-7. doi: 10.1016/j.juro.2012.04.114. Epub 2012 Jul 20.
6
Correlations among cardiovascular risk factors, prostate blood flow, and prostate volume in patients with clinical benign prostatic hyperplasia.临床良性前列腺增生患者心血管危险因素、前列腺血流与前列腺体积的相关性。
Urology. 2012 Feb;79(2):409-14. doi: 10.1016/j.urology.2011.09.039. Epub 2011 Dec 2.
7
Analysis of platelet and monocyte-to-lymphocyte ratio and diabetes mellitus with benign prostatic enlargement.血小板与单核细胞/淋巴细胞比值分析与糖尿病合并良性前列腺增生。
Front Immunol. 2023 Jul 10;14:1166265. doi: 10.3389/fimmu.2023.1166265. eCollection 2023.
8
Role of Doppler ultrasound and resistive index in benign prostatic hypertrophy.多普勒超声及阻力指数在良性前列腺增生中的作用
Int J Urol. 2002 Aug;9(8):427-30. doi: 10.1046/j.1442-2042.2002.00494.x.
9
The value of measuring the prostatic resistive index vs. pressure-flow studies in the diagnosis of bladder outlet obstruction caused by benign prostatic hyperplasia.在诊断良性前列腺增生引起的膀胱出口梗阻方面,测量前列腺阻力指数与压力-流率研究的价值。
Arab J Urol. 2012 Jun;10(2):186-91. doi: 10.1016/j.aju.2011.12.011. Epub 2012 Mar 22.
10
Obesity and benign prostatic enlargement: a large observational study in China.肥胖与良性前列腺增生:一项在中国开展的大型观察性研究。
Urology. 2007 Apr;69(4):680-4. doi: 10.1016/j.urology.2006.12.030.

引用本文的文献

1
Integrated Pharmacogenetic Signature for the Prediction of Prostatic Neoplasms in Men With Metabolic Disorders.用于预测代谢紊乱男性前列腺肿瘤的综合药物遗传学特征
Cancer Genomics Proteomics. 2025 Mar-Apr;22(2):285-305. doi: 10.21873/cgp.20502.
2
Safety and efficacy of tamsulosin 0.4 mg as an initial dose in 1,219 Korean patients with moderate to severe lower urinary tract symptoms: data from a phase IV study.坦索罗辛0.4毫克初始剂量用于1219例韩国中重度下尿路症状患者的安全性和有效性:一项IV期研究的数据
Prostate Int. 2023 Dec;11(4):228-232. doi: 10.1016/j.prnil.2023.09.003. Epub 2023 Sep 21.
3
Correlation of Doppler ultrasound resistive index in the prostatic gland with severity of male lower urinary tract symptoms, prostate volume, and concomitant diabetes mellitus.

本文引用的文献

1
Usefulness of grayscale values measuring hypoechoic lesions for predicting prostate cancer: An experimental pilot study.测量低回声病变的灰度值对预测前列腺癌的效用:一项实验性初步研究。
Prostate Int. 2022 Mar;10(1):28-33. doi: 10.1016/j.prnil.2021.11.002. Epub 2021 Dec 3.
2
An overview of benign prostatic hyperplasia and its appreciation in Greco-Arab (Unani) system of medicine.良性前列腺增生概述及其在希腊-阿拉伯(尤那尼)医学体系中的认知
Asian J Urol. 2022 Apr;9(2):109-118. doi: 10.1016/j.ajur.2021.05.008. Epub 2021 May 29.
3
Pain relieving effect of music on patients during transrectal ultrasonography: A pilot study.
前列腺多普勒超声阻力指数与男性下尿路症状严重程度、前列腺体积及合并糖尿病的相关性。
Cent European J Urol. 2023;76(3):199-206. doi: 10.5173/ceju.2023.47. Epub 2023 Jul 13.
4
Ultrasonographic Intravesical Prostatic Protrusion in Men with Benign Prostatic Hyperplasia in Southwest Nigeria.尼日利亚西南部良性前列腺增生男性的超声检查膀胱内前列腺突出情况
J West Afr Coll Surg. 2023 Apr-Jun;13(2):16-22. doi: 10.4103/jwas.jwas_270_22. Epub 2023 Mar 20.
音乐对经直肠超声检查患者的镇痛效果:一项初步研究。
Prostate Int. 2021 Dec;9(4):181-184. doi: 10.1016/j.prnil.2021.04.004. Epub 2021 May 12.
4
Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants.全球高血压患病率趋势及 1990 至 2019 年治疗和控制进展情况:1040 万参与者、1201 项人群代表性研究的汇总分析
Lancet. 2021 Sep 11;398(10304):957-980. doi: 10.1016/S0140-6736(21)01330-1. Epub 2021 Aug 24.
5
Global and national high blood pressure burden and control.全球及各国的高血压负担与控制情况
Lancet. 2021 Sep 11;398(10304):932-933. doi: 10.1016/S0140-6736(21)01688-3. Epub 2021 Aug 24.
6
Hypertension Clinical Practice Guidelines (ISH, 2020): What Is New?高血压临床实践指南(ISH,2020):有何新变化?
Med Princ Pract. 2021;30(6):579-584. doi: 10.1159/000518812. Epub 2021 Aug 2.
7
Global, Regional, and National Incidence and Year Lived with Disability for Benign Prostatic Hyperplasia from 1990 to 2019.全球、区域和国家良性前列腺增生发病率和 1990 年至 2019 年残疾年数。
Am J Mens Health. 2021 Jul-Aug;15(4):15579883211036786. doi: 10.1177/15579883211036786.
8
The rising worldwide impact of benign prostatic hyperplasia.良性前列腺增生症在全球范围内的影响日益增加。
BJU Int. 2021 Jun;127(6):722-728. doi: 10.1111/bju.15286. Epub 2020 Nov 21.
9
Prostatic artery embolization versus transurethral resection of the prostate in management of benign prostatic hyperplasia.前列腺动脉栓塞术与经尿道前列腺切除术治疗良性前列腺增生症的比较
Prostate Int. 2020 Sep;8(3):130-133. doi: 10.1016/j.prnil.2020.04.001. Epub 2020 Apr 23.
10
The global epidemiology of hypertension.高血压的全球流行病学。
Nat Rev Nephrol. 2020 Apr;16(4):223-237. doi: 10.1038/s41581-019-0244-2. Epub 2020 Feb 5.